HEARTS in the Americas : Targeting Health System Change to Improve Population Hypertension Control
© 2023. Pan American Health Organization..
PURPOSE OF REVIEW: HEARTS in the Americas is the regional adaptation of Global Hearts, the World Health Organization initiative for cardiovascular disease (CVD) prevention and control. Its overarching goal is to drive health services to change managerial and clinical practice in primary care settings to improve hypertension control and CVD risk management. This review describes the HEARTS in the Americas initiative. First, the regional epidemiological situation of CVD mortality and population hypertension control trends are summarized; then the rationale for its main intervention components: the primary care-oriented management system and the HEARTS Clinical Pathway are described. Finally, the key factors for accelerating the expansion of HEARTS are examined: medicines, team-based care, and a system for monitoring and evaluation.
RECENT FINDINGS: Thus far, 33 countries in Latin America and the Caribbean have committed to integrating this program across their primary healthcare network by 2025. The increase in hypertension coverage and control in primary health care settings compared with the traditional model is promising and confirms that the interventions under the HEARTS umbrella are feasible and acceptable to communities, patients, providers, decision-makers, and funders. This review highlights some cases of successful implementation. Scaling up effective treatment for hypertension and optimization of CVD risk management is a pragmatic way to accelerate the reduction of CVD mortality while strengthening primary healthcare systems to respond effectively, with quality, and equitably, to the challenge of non-communicable diseases, not only in low-middle income countries but in all communities globally.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Current hypertension reports - 26(2024), 4 vom: 29. März, Seite 141-156 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ordunez, Pedro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Americas |
|---|
| Anmerkungen: |
Date Completed 01.03.2024 Date Revised 03.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11906-023-01286-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36532714X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36532714X | ||
| 003 | DE-627 | ||
| 005 | 20240303231850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11906-023-01286-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1315.xml |
| 035 | |a (DE-627)NLM36532714X | ||
| 035 | |a (NLM)38041725 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ordunez, Pedro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HEARTS in the Americas |b Targeting Health System Change to Improve Population Hypertension Control |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.03.2024 | ||
| 500 | |a Date Revised 03.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Pan American Health Organization. | ||
| 520 | |a PURPOSE OF REVIEW: HEARTS in the Americas is the regional adaptation of Global Hearts, the World Health Organization initiative for cardiovascular disease (CVD) prevention and control. Its overarching goal is to drive health services to change managerial and clinical practice in primary care settings to improve hypertension control and CVD risk management. This review describes the HEARTS in the Americas initiative. First, the regional epidemiological situation of CVD mortality and population hypertension control trends are summarized; then the rationale for its main intervention components: the primary care-oriented management system and the HEARTS Clinical Pathway are described. Finally, the key factors for accelerating the expansion of HEARTS are examined: medicines, team-based care, and a system for monitoring and evaluation | ||
| 520 | |a RECENT FINDINGS: Thus far, 33 countries in Latin America and the Caribbean have committed to integrating this program across their primary healthcare network by 2025. The increase in hypertension coverage and control in primary health care settings compared with the traditional model is promising and confirms that the interventions under the HEARTS umbrella are feasible and acceptable to communities, patients, providers, decision-makers, and funders. This review highlights some cases of successful implementation. Scaling up effective treatment for hypertension and optimization of CVD risk management is a pragmatic way to accelerate the reduction of CVD mortality while strengthening primary healthcare systems to respond effectively, with quality, and equitably, to the challenge of non-communicable diseases, not only in low-middle income countries but in all communities globally | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Americas | |
| 650 | 4 | |a Cardiovascular diseases | |
| 650 | 4 | |a Hypertension | |
| 650 | 4 | |a Primary health care | |
| 650 | 4 | |a Public health | |
| 700 | 1 | |a Campbell, Norm R C |e verfasserin |4 aut | |
| 700 | 1 | |a DiPette, Donald J |e verfasserin |4 aut | |
| 700 | 1 | |a Jaffe, Marc G |e verfasserin |4 aut | |
| 700 | 1 | |a Rosende, Andres |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez, Ramon |e verfasserin |4 aut | |
| 700 | 1 | |a Gamarra, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Lombardi, Cintia |e verfasserin |4 aut | |
| 700 | 1 | |a Parra, Natalia |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez, Libardo |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez, Yenny |e verfasserin |4 aut | |
| 700 | 1 | |a Brettler, Jeffrey |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current hypertension reports |d 1999 |g 26(2024), 4 vom: 29. März, Seite 141-156 |w (DE-627)NLM109021290 |x 1534-3111 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:4 |g day:29 |g month:03 |g pages:141-156 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11906-023-01286-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2024 |e 4 |b 29 |c 03 |h 141-156 | ||